Dynamic microRNA activity identifies therapeutic targets in trastuzumab ‐resistant HER2+ breast cancer
Biotechnology and Bioengineering, EarlyView.
Source: Biotechnology and Bioengineering - Category: Biomedical Science Authors: Joseph T.Decker
,
Matthew S.Hall
,
Rachel B.Blaisdell
,
KallenSchwark
,
Jacqueline S.Jeruss
,
Lonnie D.Shea Source Type: research
More News: Biomedical Science | Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin